Market Overview

Amylin Pharmaceuticals Announces Public Offering of Common Stock; No Amount Given


Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is offering to sell shares of its common stock in an underwritten public offering.

Credit Suisse Securities LLC is acting as sole book-running manager and underwriter in this offering.

Posted-In: News Offerings


Related Articles (AMLN)

View Comments and Join the Discussion!